SEC 13F Intelligence

Arnhold LLC / BMY

Arnhold LLC’s Bristol-Myers Squibb Co Position

Does Arnhold LLC own Bristol-Myers Squibb Co (BMY)? Yes391.0K shares worth $24M (+1.74% of its 13F portfolio) as of Q1 2026.

Position Value
$24M
Q1 2026
Shares
391.0K
% of Portfolio
+1.74%
Quarters Held
30
currently held

Position History BMY

Reported value by quarter
Q4 ’18: $11MQ4 ’18Q1 ’19: $13MQ2 ’19: $15MQ3 ’19: $18MQ4 ’19: $15MQ4 ’19Q1 ’20: $15MQ2 ’20: $18MQ3 ’20: $18MQ4 ’20: $19MQ4 ’20Q1 ’21: $19MQ2 ’21: $20MQ3 ’21: $18MQ4 ’21: $27MQ4 ’21Q1 ’22: $23MQ2 ’22: $18MQ3 ’22: $17MQ4 ’22: $16MQ4 ’22Q1 ’23: $16MQ2 ’23: $15MQ3 ’23: $15MQ4 ’23: $16MQ4 ’23Q1 ’24: $19MQ2 ’24: $21MQ3 ’24: $24MQ4 ’24: $25MQ4 ’24Q1 ’25: $24MQ2 ’25: $18MQ3 ’25: $18MQ4 ’25: $21MQ4 ’25Q1 ’26: $24Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026391.0K$24M+1.74%
Q4 2025391.0K$21M+1.60%
Q3 2025391.0K$18M+1.47%
Q2 2025394.0K$18M+1.66%
Q1 2025394.0K$24M+2.43%
Q4 2024435.3K$25M+2.43%
Q3 2024471.9K$24M+2.37%
Q2 2024502.8K$21M+2.20%
Q1 2024356.7K$19M+2.05%
Q4 2023319.8K$16M+1.83%
Q3 2023255.3K$15M+1.77%
Q2 2023231.7K$15M+1.68%
Q1 2023233.7K$16M+1.84%
Q4 2022229.1K$16M+2.02%
Q3 2022238.9K$17M+2.28%
Q2 2022238.9K$18M+2.20%
Q1 2022309.1K$23M+2.54%
Q4 2021437.7K$27M+3.09%
Q3 2021310.2K$18M+2.12%
Q2 2021305.6K$20M+2.31%
Q1 2021306.1K$19M+2.32%
Q4 2020306.0K$19M+2.46%
Q3 2020306.1K$18M+2.73%
Q2 2020306.1K$18M+2.86%
Q1 2020262.6K$15M+2.70%
Q4 2019239.1K$15M+2.42%
Q3 2019346.3K$18M+2.98%
Q2 2019328.7K$15M+2.61%
Q1 2019274.4K$13M+2.36%
Q4 2018211.1K$11M+2.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Arnhold LLC’s full portfolio or all institutional holders of BMY.